Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
Beta Bionics faces a securities class action over claims tied to its iLet automated insulin delivery system and alleged failures around FDA concerns. The case seeks to represent investors who bought the stock between July 30, 2025 and Feb. 24, 2026.
Beta Bionics faces a securities class action tied to allegations over disclosures about its iLet automated insulin delivery system and FDA concerns. The suit seeks to represent investors who bought shares between July 30, 2025 and Feb. 24, 2026.